Medicare is bracing for significant shifts under a new Administration including a push for broader private-sector involvement. Other areas to watch include a renewed focus on member satisfaction in star ratings, a potential rollback of health equity initiatives, and changes to regulations governing Medicare field marketing organizations. Additionally, there is speculation about the future of Medicare's drug price negotiation program, with possibilities ranging from maintaining the current approach to repealing it entirely. The next four years are certain to bring changes to the program, impacting providers and beneficiaries alike so let's hear from the foremost expert in all things Medicare and MA.